Liu JF, Brady MF, Matulonis UA, Miller A, et al. Olaparib With or Without Cediranib Versus Platinum-Based Chemotherapy in Recurrent Platinum-Sensitive Ovarian Cancer (NRG-GY004): A Randomized, Open-Label, Phase III Trial. J Clin Oncol 2022 Mar 15:JCO2102011. doi: 10.1200/JCO.21.02011.
PMID: 35290101